Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Oct;8(4):699-714.
doi: 10.1111/j.1750-3639.1998.tb00196.x.

Transgenic mice in the study of polyglutamine repeat expansion diseases

Affiliations
Review

Transgenic mice in the study of polyglutamine repeat expansion diseases

G P Bates et al. Brain Pathol. 1998 Oct.

Abstract

An increasing number of neurodegenerative diseases, including Huntington's disease (HD), have been found to be caused by a CAG/polyglutamine expansion. We have generated a mouse model of HD by the introduction of exon 1 of the human HD gene carrying highly expanded CAG repeats into the mouse germ line. These mice develop a progressive neurological phenotype. Neuronal intranuclear inclusions (NII) that are immunoreactive for huntingtin and ubiquitin have been found in the brains of symptomatic mice. In vitro analysis indicates that the inclusions are formed through self aggregation via the polyglutamine repeat into amyloid-like fibrils composed of a cross beta-sheet structure that has been termed a polar zipper. Analysis of patient material and other transgenic lines has now shown NII to be a common feature of all of these diseases. In the transgenic models, inclusions are present prior to the onset of symptoms suggesting a causal relationship. In contrast, neurodegeneration occurs after the onset of the phenotype indicating that the symptoms are caused by a neuronal dysfunction rather than a primary cell death.

PubMed Disclaimer

References

    1. Ambrose CM , Duyao MP , Barnes G , Bates GP , Lin CS , Srinidhi J , Baxendale S , Hummerich H , Lehrach H , Altherr M , Wasmuth J , Buckler A , Church D , Housman D , Berks M , Micklem G , Durbin R , Dodge A , Read A , Gusella J , MacDonald ME ( 1993. ) Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat . Somatic Cell Mol. Genet. 20 : 27 – 38 . - PubMed
    1. Banfi S , Servadio A , Chung M , Kwiatkowski T , McCall AE , Duvick L , Shen Y , Roth EJ , Orr HT , Zoghbi HY ( 1994. ) Identification and characterisation of the gene causing type 1 spinocerebellar ataxia . Nature Genet. 7 : 513 – 520 . - PubMed
    1. Baxendale S , Abdulla S , Elgar G , Bucks D , Berks M , Micklem G , Durbin R , Bates G , Brenner S , Beck S , Lehrach H ( 1995. ) Comparative sequence analysis of the human and puffer fish Huntington's disease gene . Nature Genet. 10 : 67 – 75 . - PubMed
    1. Becher MW , Kotzuk JA , Sharp AH , Davies SW , Bates GP , Price DL , Ross CA ( 1998. ) Intranuclear neuronal inclusions in Huntington's disease and dentatorubral pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG repeat length . Neurobiol. Dis. 4 : 387 – 397 . - PubMed
    1. Bertaux F , Sharp AH , Ross CA , Lehrach H , Bates GP , Wanker EE ( 1998. ) HAP1‐huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice . FEBS Lett. 426 : 229 – 232 . - PubMed

Publication types

LinkOut - more resources